Pomanda estimates the enterprise value of FULFORD PHARMACY LIMITED at £219.8k based on a Turnover of £644.6k and 0.34x industry multiple (adjusted for size and gross margin).
fulford pharmacy limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of FULFORD PHARMACY LIMITED at £0 based on an EBITDA of £-40.3k and a 3.76x industry multiple (adjusted for size and gross margin).
fulford pharmacy limitedEstimated Valuation
£595.5k
Pomanda estimates the enterprise value of FULFORD PHARMACY LIMITED at £595.5k based on Net Assets of £300.8k and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Fulford Pharmacy LimitedOverview
Fulford Pharmacy Limited is a live company located in york, YO32 5WD with a Companies House number of 01657353. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in August 1982, it's largest shareholder is
fulford pharma limited
with a 100% stake. Fulford Pharmacy Limited is a mature,
small sized company, Pomanda has estimated its turnover at
£644.6k with
declining
growth in recent years.
Pomanda's financial health check has awarded Fulford Pharmacy Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating4out of 5
4 Strong
2 Regular
6 Weak
Size
annual sales of £644.6k, make it smaller than the average company (£13.6m)
£644.6k - Fulford Pharmacy Limited
£13.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -6%, show it is growing at a slower rate (7.6%)
-6% - Fulford Pharmacy Limited
7.6% - Industry AVG
Production
with a gross margin of 31.4%, this company has a comparable cost of product (31.4%)
31.4% - Fulford Pharmacy Limited
31.4% - Industry AVG
Profitability
an operating margin of -7.6% make it less profitable than the average company (2.3%)
-7.6% - Fulford Pharmacy Limited
2.3% - Industry AVG
Employees
with 5 employees, this is below the industry average (72)
5 - Fulford Pharmacy Limited
72 - Industry AVG
Pay Structure
on an average salary of £28.8k, the company has an equivalent pay structure (£28.8k)
£28.8k - Fulford Pharmacy Limited
£28.8k - Industry AVG
Efficiency
resulting in sales per employee of £128.9k, this is less efficient (£157.8k)
£128.9k - Fulford Pharmacy Limited
£157.8k - Industry AVG
Debtor Days
it gets paid by customers after 39 days, this is later than average (28 days)
39 days - Fulford Pharmacy Limited
28 days - Industry AVG
Creditor Days
its suppliers are paid after 82 days, this is slower than average (60 days)
82 days - Fulford Pharmacy Limited
60 days - Industry AVG
Stock Days
it holds stock equivalent to 25 days, this is less than average (34 days)
25 days - Fulford Pharmacy Limited
34 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 66 weeks, this is more cash available to meet short term requirements (11 weeks)
66 weeks - Fulford Pharmacy Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 32.1%, this is a lower level of debt than the average (59.3%)
32.1% - Fulford Pharmacy Limited
59.3% - Industry AVG
FULFORD PHARMACY LIMITED financials
EXPORT
Fulford Pharmacy Limited's latest turnover from August 2024 is estimated at £644.6 thousand and the company has net assets of £300.8 thousand. According to their latest financial statements, Fulford Pharmacy Limited has 5 employees and maintains cash reserves of £181.5 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Aug 2024
Aug 2023
Aug 2022
Aug 2021
Aug 2020
Aug 2019
Aug 2018
Aug 2017
Aug 2016
Aug 2015
Aug 2014
Aug 2013
Aug 2012
Aug 2011
Aug 2010
Aug 2009
Turnover
644,563
810,357
646,126
784,294
657,847
449,653
404,319
590,378
654,726
1,033,009
714,459
421,025
451,913
565,761
738,441
Other Income Or Grants
Cost Of Sales
442,149
549,370
429,743
528,862
453,864
309,038
273,844
399,508
444,875
722,654
494,906
288,539
316,369
397,868
514,896
Gross Profit
202,414
260,987
216,383
255,432
203,983
140,614
130,475
190,869
209,851
310,355
219,553
132,486
135,544
167,893
223,545
Admin Expenses
251,393
230,736
123,166
321,958
157,859
146,217
173,540
159,590
212,376
378,791
197,611
135,112
154,027
194,740
219,932
-528,625
Operating Profit
-48,979
30,251
93,217
-66,526
46,124
-5,603
-43,065
31,279
-2,525
-68,436
21,942
-2,626
-18,483
-26,847
3,613
528,625
Interest Payable
Interest Receivable
7,451
7,394
2,226
127
131
887
819
156
88
499
972
1,027
1,022
1,049
1,023
502
Pre-Tax Profit
-41,528
37,645
95,443
-66,399
46,254
-4,716
-42,246
31,436
-2,437
-67,937
22,914
-1,599
-17,461
-25,798
4,636
529,126
Tax
-9,411
-18,134
-8,788
-5,973
-4,812
-1,298
-148,155
Profit After Tax
-41,528
28,234
77,309
-66,399
37,466
-4,716
-42,246
25,463
-2,437
-67,937
18,102
-1,599
-17,461
-25,798
3,338
380,971
Dividends Paid
Retained Profit
-41,528
28,234
77,309
-66,399
37,466
-4,716
-42,246
25,463
-2,437
-67,937
18,102
-1,599
-17,461
-25,798
3,338
380,971
Employee Costs
143,987
128,784
168,074
135,209
105,426
105,769
81,197
132,930
162,578
159,215
123,368
67,680
67,985
85,917
100,932
Number Of Employees
5
5
7
6
5
5
4
7
9
9
7
4
4
5
6
EBITDA*
-40,257
41,322
107,508
-64,025
48,891
-2,689
-36,553
34,653
1,272
-63,919
25,534
1,236
-14,115
-22,129
7,994
533,370
* Earnings Before Interest, Tax, Depreciation and Amortisation
Aug 2024
Aug 2023
Aug 2022
Aug 2021
Aug 2020
Aug 2019
Aug 2018
Aug 2017
Aug 2016
Aug 2015
Aug 2014
Aug 2013
Aug 2012
Aug 2011
Aug 2010
Aug 2009
Tangible Assets
138,232
146,898
157,969
124,090
126,591
127,999
130,913
133,237
136,392
139,161
133,635
135,751
139,613
141,641
147,828
152,133
Intangible Assets
Investments & Other
967
967
967
967
967
967
Debtors (Due After 1 year)
Total Fixed Assets
138,232
146,898
157,969
124,090
126,591
127,999
130,913
133,237
136,392
139,161
134,602
136,718
140,580
142,608
148,795
153,100
Stock & work in progress
31,322
27,877
29,012
31,344
29,722
33,504
31,080
30,140
32,002
30,221
42,485
42,052
43,890
48,680
57,213
52,957
Trade Debtors
69,955
124,928
61,620
110,098
96,209
44,835
41,403
83,466
76,484
176,788
103,064
52,106
62,722
95,326
113,357
115,178
Group Debtors
15,100
21,100
35,000
49,400
54,400
64,400
Misc Debtors
21,649
23,263
17,339
14,238
15,868
6,848
16,290
14,096
13,038
Cash
181,522
116,536
165,147
89,235
164,594
96,789
139,755
78,659
46,411
23,650
176,095
212,862
197,978
210,882
208,577
200,714
misc current assets
total current assets
304,448
292,604
273,118
260,015
327,493
216,976
277,928
260,761
232,335
230,659
321,644
307,020
304,590
354,888
379,147
368,849
total assets
442,680
439,502
431,087
384,105
454,084
344,975
408,841
393,998
368,727
369,820
456,246
443,738
445,170
497,496
527,942
521,949
Bank overdraft
Bank loan
Trade Creditors
99,625
83,660
73,346
74,677
111,609
73,024
78,349
69,441
76,714
77,806
96,812
102,430
101,157
106,216
140,275
137,408
Group/Directors Accounts
33
33
33
34
846
30,846
other short term finances
hp & lease commitments
other current liabilities
42,189
13,270
42,720
70,903
37,364
4,217
58,218
9,698
2,587
total current liabilities
141,814
96,930
116,066
145,580
148,973
77,274
136,600
79,172
79,335
77,806
96,812
102,430
102,003
137,062
140,275
137,408
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
91
269
952
1,765
1,952
2,008
1,832
2,171
2,201
2,386
1,869
1,845
2,115
1,921
3,356
3,568
total long term liabilities
91
269
952
1,765
1,952
2,008
1,832
2,171
2,201
2,386
1,869
1,845
2,115
1,921
3,356
3,568
total liabilities
141,905
97,199
117,018
147,345
150,925
79,282
138,432
81,343
81,536
80,192
98,681
104,275
104,118
138,983
143,631
140,976
net assets
300,775
342,303
314,069
236,760
303,159
265,693
270,409
312,655
287,191
289,628
357,565
339,463
341,052
358,513
384,311
380,973
total shareholders funds
300,775
342,303
314,069
236,760
303,159
265,693
270,409
312,655
287,191
289,628
357,565
339,463
341,052
358,513
384,311
380,973
Aug 2024
Aug 2023
Aug 2022
Aug 2021
Aug 2020
Aug 2019
Aug 2018
Aug 2017
Aug 2016
Aug 2015
Aug 2014
Aug 2013
Aug 2012
Aug 2011
Aug 2010
Aug 2009
Operating Activities
Operating Profit
-48,979
30,251
93,217
-66,526
46,124
-5,603
-43,065
31,279
-2,525
-68,436
21,942
-2,626
-18,483
-26,847
3,613
528,625
Depreciation
8,722
11,071
14,291
2,501
2,767
2,914
3,256
3,374
3,797
4,517
3,592
3,862
4,368
4,718
4,381
4,745
Amortisation
3,256
Tax
-9,411
-18,134
-8,788
-5,973
-4,812
-1,298
-148,155
Stock
3,445
-1,135
-2,332
1,622
-3,782
2,424
940
-1,862
1,781
-12,264
433
-1,838
-4,790
-8,533
4,256
52,957
Debtors
-56,587
69,232
-60,477
6,259
46,494
-20,410
-44,869
-1,960
-22,866
73,724
50,958
-10,616
-32,604
-18,031
-1,821
115,178
Creditors
15,965
10,314
-1,331
-36,932
38,585
-5,325
8,908
-7,273
-1,092
-19,006
-5,618
1,273
-5,059
-34,059
2,867
137,408
Accruals and Deferred Income
28,919
-29,450
-28,183
33,539
33,147
-54,001
48,520
7,111
2,587
Deferred Taxes & Provisions
-178
-683
-813
-187
-56
176
-339
-30
-185
517
24
-270
194
-1,435
-212
3,568
Cash flow from operations
57,591
-56,005
121,856
-75,486
69,067
-43,853
64,465
32,310
23,667
-143,868
-36,263
14,693
18,414
-31,059
6,916
358,056
Investing Activities
capital expenditure
-56
-48,170
-1,359
-4,188
-219
-1,028
-10,043
-1,476
-2,340
1,469
-76
-156,878
Change in Investments
-967
967
cash flow from investments
-56
-48,170
-1,359
-4,188
-219
-1,028
-9,076
-1,476
-2,340
1,469
-76
-157,845
Financing Activities
Bank loans
Group/Directors Accounts
-33
-1
34
-846
-30,000
30,846
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
1
10
2
interest
7,451
7,394
2,226
127
131
887
819
156
88
499
972
1,027
1,022
1,049
1,023
502
cash flow from financing
7,451
7,394
2,226
127
98
887
819
156
122
499
972
191
-28,978
31,895
1,023
504
cash and cash equivalents
cash
64,986
-48,611
75,912
-75,359
67,805
-42,966
61,096
32,248
22,761
-152,445
-36,767
14,884
-12,904
2,305
7,863
200,714
overdraft
change in cash
64,986
-48,611
75,912
-75,359
67,805
-42,966
61,096
32,248
22,761
-152,445
-36,767
14,884
-12,904
2,305
7,863
200,714
fulford pharmacy limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for fulford pharmacy limited. Get real-time insights into fulford pharmacy limited's credit score, group structure and payment trends.
Perform a competitor analysis for fulford pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in YO32 area or any other competitors across 12 key performance metrics.
fulford pharmacy limited Ownership
FULFORD PHARMACY LIMITED group structure
Fulford Pharmacy Limited has no subsidiary companies.
3 bonneycroft, strensall, york, north yorkshire, YO32 5WD
Bank
-
Legal Advisor
-
fulford pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to fulford pharmacy limited. Currently there are 0 open charges and 2 have been satisfied in the past.
fulford pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for FULFORD PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
fulford pharmacy limitedCompanies House Filings - See Documents
